analyst
VE
NASDAQ · VERA
Vera Therapeutics, Inc.
Healthcare · Biotechnology
$30.42
Down-$0.57 (-1.84%)
Updated Oct 5, 2026, 6:21 AM
SID Score
4.0/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 2.94B
- P/E ratio
- -13.44
- Dividend yield
- 0.00%
- 52-week range
- $28.86 – $47.00
- Volume
- 1.61M
- Avg. volume
- 1.59M
Price performance · VERA
VERA price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
VERA closed at $30.42 after 19 trading sessions, down 13.78% for the selected period.
- Last close
- $30.42
- Period change
- -13.78%
- Period low
- $30.42
- Period high
- $36.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $31.16 | $31.27 | $29.80 | $30.42 | 1.61M |
| Oct 1, 2026 | $32.14 | $32.44 | $30.87 | $30.99 | 1.01M |
| Sep 30, 2026 | $32.57 | $33.60 | $32.20 | $32.29 | 1.8M |
| Sep 29, 2026 | $32.50 | $32.84 | $31.90 | $32.375 | 1.46M |
| Sep 28, 2026 | $32.34 | $33.04 | $31.42 | $32.50 | 1.46M |
| Sep 25, 2026 | $33.34 | $33.44 | $32.46 | $32.54 | 1.25M |
| Sep 24, 2026 | $32.72 | $33.68 | $32.23 | $33.34 | 1.69M |
| Sep 23, 2026 | $36.27 | $36.50 | $32.63 | $33.05 | 2.02M |
| Sep 22, 2026 | $34.67 | $36.50 | $34.295 | $36.26 | 1.98M |
| Sep 21, 2026 | $34.50 | $34.98 | $33.65 | $34.25 | 1.23M |
| Sep 18, 2026 | $34.56 | $34.56 | $33.08 | $34.00 | 4.19M |
| Sep 17, 2026 | $32.50 | $36.23 | $32.50 | $34.27 | 3.89M |
| Sep 16, 2026 | $33.22 | $34.00 | $31.1901 | $31.77 | 3.91M |
| Sep 15, 2026 | $37.14 | $37.14 | $32.73 | $33.67 | 10.49M |
| Sep 14, 2026 | $35.11 | $35.535 | $33.22 | $34.05 | 1.71M |
| Sep 11, 2026 | $33.91 | $35.29 | $33.75 | $35.05 | 3.8M |
| Sep 10, 2026 | $33.49 | $34.29 | $32.88 | $33.60 | 2.03M |
| Sep 9, 2026 | $34.84 | $35.4829 | $33.75 | $33.78 | 939.21K |
| Sep 8, 2026 | $35.80 | $35.995 | $34.885 | $35.28 | 1.44M |
Latest VERA news
The latest Smart Investors Daily articles mentioning VERA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

